Patent Expands Niagen’s Leadership in NAD+ Delivery, Supporting Faster and Safer Treatments Why is the race for intellectual property in the NAD+ market heating up? Niagen Bioscience, Inc. a global…
Hawks and Ressler Gertz Family Foundation Boost Prostate Cancer Research with $150,000 Donation Why is prostate cancer awareness and research crucial in the sports industry? The Atlanta Hawks Foundation, in…
Real-World Impact of ZUNVEYL in Long-Term Care to Be Assessed What does the future hold for Alzheimer’s disease treatment in long-term care settings? Alpha Cognition Inc. a biopharmaceutical company focused…
Strategic Collaboration to Convene Global Investors and Leaders for Healthcare Advancement Why is the Middle East emerging as a critical hub for healthcare innovation? NYU Abu Dhabi and RTW Investments,…
Strategic License Agreement Advances Novel Compounds for Autoimmune Diseases Why are autoimmune diseases still a significant challenge for pharmaceutical companies? Asahi Kasei Pharma, a global leader in drug development, is…
Chemify and Sanacor Join Forces to Tackle Diabetic Cardiovascular Disease Why is the discovery of new therapies for diabetic cardiovascular disease so critical? Chemify, a deep-tech pioneer in Chemputation, and…
Enveric Biosciences Overcomes Legal Hurdles to Protect Innovative Neuroplastogenic Therapeutics What does the withdrawal of a patent challenge mean for a biotech company’s intellectual property and future innovations? Enveric Biosciences…
Kivu Bioscience Secures HREC Approval and CTN Clearance for Next-Generation ADC Why are next-generation antibody-drug conjugates (ADCs) crucial for advancing cancer treatments? Kivu Bioscience, a clinical-stage biotechnology company based in…
Ironwood Strengthens LINZESS Market Leadership and Prepares for Apraglutide Phase 3 Trials Why are biotechnology companies like Ironwood Pharmaceuticals crucial in addressing unmet needs in gastrointestinal diseases? Ironwood Pharmaceuticals, a…
Ionis Poised for Continued Growth with Multiple Upcoming Therapeutic Launches Is the biotech industry ready for a new wave of transformative therapies? Ionis Pharmaceuticals, a leader in RNA-targeted therapies, reported…
IQVIA Strengthens Early-Stage Discovery Research with Advanced In Vitro and AI-Driven Solutions Why is the life sciences industry facing a critical need for accelerated drug discovery? IQVIA Holdings Inc. a…
Funding Boosts Development of NanoGalaxy Platform and Lead Candidate BRZ-101 for Type 1 Diabetes Why is targeted gene delivery a critical challenge in the biotech industry? BreezeBio, a biotechnology company…
